People live on average a little over two years after an mCRPC diagnosis. Find statistics here and learn how treatment ...

It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

Decipher Prostate Metastatic Genomic Classifier is now available for patients with metastatic prostate cancer.

Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

“Our expansion into metastatic prostate cancer underscores ... Clinical qualification of transcriptome signatures for advanced prostate cancer (APC) starting androgen deprivation therapy ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.